1
Beyond patient support & medication adherence…
Maximizing patient happiness & outcomes…via patient engagement & empowerment
www.rxandyou.comWWW.BIOINFORMATIX.IOOCTOBER 2016
The Problem: Three Core Issues in Medication Delivery +
Medication Non-Adherence
Poly-Provider & Poly-Pharmacy
Drug Interactions & Adverse Events
Medication Non-Adherence – On average, 50% of Americans do not take their drug regimens as prescribed and fall off their treatment path, costing payers $5K each per year; 60% simply forget how to follow the path.
Drug Interactions & Adverse Events – Prescription drug interactions kill 180,000 Americans yearly; it is the 4th leading cause of death.
Poly-Provider – The average American adult sees 18 providers, 28 providers for older or sicker Americans; many don’t know of each others’ existence, let alone what they’re doing.
2OCTOBER 2016 BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
Three preventable health-management issues cost approximately 420,000 lives and US$664 billion per year:
3
Introducing: A Complete Patient Engagement And Safety System A Single Solution with 8 Modules that Engage Patients in Real-time on Preferred Devices to Prevent Issues, Monitor and Report Events, and Coordinate Care
OCTOBER 2016 BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
AdverseDrug
Interactions
Interaction Screener
Medication Non-
Adherence
Regimen Reminder
Adherence Barriers
Non-adherence
query, reporting
Confused Patients
Micro-targeted Patient
Education
Complex Healthcare
System
Interchange for all
Docs/Meds Info
Adverse Drug
Events
Direct e-reporting
of AEs
Lack of Cross
Provider Visibility
Cross Provider
Care Coordinatio
n
Failure to Surface Adverse
Outcomes
Predictive Analytics
Problems
Solutions
4
What does it do for patients? Engage in Real-time on Preferred Devices to Monitor Medication Events & Alert Providers to Prevent Medical Consequences
OCTOBER 2016 BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
5
What does it do for providers? Engage Patients in Real-time on Preferred Devices to Monitor Medication Events & Alert Providers to Prevent Medical Consequences
OCTOBER 2016 BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
Gaining Traction & Ready to Scale Rx&You is complete, with a scalable architecture and AI innovations that are attracting customers and earning national award nominations
6OCTOBER 2016 BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
1. Built and Tested 2. Starting Pilots 3. IP Locked
Counsel to…
4. Deep AI 5. Super Scalable
+
= Personalized Medicine
B2B2C +Payers +
Pharma +Providers =
Largest Medication
Big Data Repository
In 18-24 mo
7BIOINFORMATIX.IO - STRICTLY CONFIDENTIALOCTOBER 2016
GTM: Scalable, Innovative Sales Model Offer: To only charge a % of savings generated -- at 20%, that is potentially $10B/yr.
Medical Insurers
Workers’ Comp.
Insurers
Medical Research Centers
Pharmas
National Health
Services
Patients: 20-80M EachSavings: $1-4B yearNPV: $200-800M year
Patients: 20-80M EachSavings: $1-4B yearNPV: $200-800M year
TBD Value TBD Value
Patients: 1-4M EachSavings: $5-20M yearNPV: $200-800M year
x30
x12
x12
x100 x12
OCTOBER 2016
What could this mean? Lives Saved One US Payer = 25,000 lives saved per yearOne Country NHS = 23,000 lives saved per year
8BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
10 Largest Medical Insurers:
1. Zurich2. Express Scripts3. United4. Aviva5. Axa6. Anthem (BC/BS)7. Aetna8. AIA9. Allianz10. Humana
= up to $4 billion in annual licensing fees at 20% of cost savings
What could this mean? Billions Saved Billions in New Profits for US Insurers –charts below model one insurer’s savings
OCTOBER 2016 9BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
10 of top 30 National Health Services:
1. Norway2. Japan3. United Kingdom4. Sweden5. Saudi Arabia6. Canada7. Italy8. Portugal9. Spain10. UAE, Kuwait & Bahrain
= Up to $1.6 billion in annual licensing fees at 20% of projected cost savings
Optimal for National Health Services Billions in Savings for National Health Services – below is a typical model
OCTOBER 2016 10BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
Appendix
OCTOBER 2016 11BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
12
Scale of these problemsMedication Adherence + Pharmacovigilance + Care Coordination
OCTOBER 2016 BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
13
Scale of these problemsMedication Adherence + Pharmacovigilance + Care Coordination
OCTOBER 2016 BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
14
Scale of these problemsMedication Adherence + Pharmacovigilance + Care Coordination
OCTOBER 2016 BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
Our Intentions & TrajectoryDo Well while Doing Good
$40m net earnings$200m valuation50m patients engaged25,000 lives savedAugust 2017
$150m recurring revenue$1.4B payer savings100m patients engaged1m AE identifiedAugust 2018 $1B valuation
$3B in payer savings#1 Big Data med dbDecember 2018
OCTOBER 2016 15BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
A Competitively Superior Solution
Delivers Big Data
Regimen reminders
E-reports adverse events ?
Patient Education ?
Poly-provider ?
Care coordination ?
Mobilized (iPad, iPhone)
Drug interaction screens ?
AI to Detect & Prevent Risks ?
Licensees – Who pays? Patients Patients & Providers Patients Providers Payers & Pharma
Ability to Pay
OCTOBER 2016 16BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL
The Pharma Problems we SolveAn Inter-departmental Enterprise Intelligence Platform
Clinical Trial Departments1. Creates single-view to disparate clinical trials data in real-time;2. Standardizes data types and meanings across clinical trials and stores for long-term re-use and
R&D;3. Maximizes clinical trial outcomes by maximizing medication adherence;4. Using TSQ measurements attached to each patient regimen, creates data to comparatively rank
every med by effectiveness, value, and safety;Clinical Care or Patient Support Departments5. Engages patients in real-time to always know how to take meds eliminating up to 60% of non-
adherence;6. Could prevent nearly 100% of drug-drug interactions;7. Can predict patients’ probability of becoming non-adherent and intervene to prevent;Marketing Departments8. Freely distributes and tracks patient ed, micro-targeting on preferred device to ensure every
patient gets all materials regimen-wide;9. Learn how getting the right info to the right patient at the right time improves clinical outcomes;Regulatory Departments10. Maximizes the percentage of adverse-events that get timely reported;11. Maximizes the qualitative information (e.g., other meds) associated with adverse events; and,12. Maximizes the timeliness of AE reporting to all healthcare teams, manufacturers, and public
health agencies.OCTOBER 2016 17BIOINFORMATIX.IO - STRICTLY CONFIDENTIAL